Louise Frederika Kooij, Chief Accounting Officer at NewAmsterdam Pharma Co N.V. (NAMS), sold 36,146 shares at $25.09 ($907K) on 2025-09-03, disclosed to the SEC on 2025-09-05.
Open-market sale of $907k NAMS by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.09 | 18,073 | $453K | 50.0% |
| 2 | $25.09 | 18,073 | $453K | 50.0% |
| Total | $25.09 avg | 36,146 | $907K | 100% |
| Filing → |
| NAMS | SELL | 2026-05-27 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-29 | $2.3M | — | Filing → |
| NAMS | SELL | 2026-01-27 | $2.4M | — | Filing → |